BIOMAT Database Logo BIOMAT Database Logo

[Glucuronyl-glycosamino-glycan sulfate in the therapy of diabetic patients]. 1977

O Longo, and S Branca, and M Aloisio

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006025 Glycosaminoglycans Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE). Glycosaminoglycan,Mucopolysaccharides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride

Related Publications

O Longo, and S Branca, and M Aloisio
[Rapid changes in blood lipid parameters induced by glucuronyl glucosamine glycan sulfate in obese diabetic and hyperlipidemia patients].
January 1982, Archivio per le scienze mediche,
O Longo, and S Branca, and M Aloisio
[Activity of glucuronyl-glucosamine-glycan sulfate in patients with dyslipemia. Medium-term study].
May 1975, La Clinica terapeutica,
O Longo, and S Branca, and M Aloisio
[Effects of glucuronyl-glucosamino-glycan sulfate in a group of patients with blood lipid disorders].
January 1979, La Clinica terapeutica,
O Longo, and S Branca, and M Aloisio
[The use of glucuronyl glucosamine glycan sulfate in dyslipidemic subjects with labyrinth disease].
December 1980, Giornale di clinica medica,
O Longo, and S Branca, and M Aloisio
[Rapid effect of glucuronyl glucosamine glycan sulfate on the blood levels of HDL-cholesterol in vascular diseases].
January 1982, Archivio per le scienze mediche,
O Longo, and S Branca, and M Aloisio
[Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].
November 1974, Minerva medica,
O Longo, and S Branca, and M Aloisio
[The use of glucuronyl-glucosamino-glycan sulfate (3GS) in the treatment of cerebral and peripheral athero-arteriosclerotic pathology].
March 1978, La Clinica terapeutica,
O Longo, and S Branca, and M Aloisio
Irreversible glucuronyl C5-epimerization in the biosynthesis of heparan sulfate.
April 2004, The Journal of biological chemistry,
O Longo, and S Branca, and M Aloisio
Feasible synthesis and biological properties of six 'non-glycosamino' glycan analogues of the antithrombin III binding heparin pentasaccharide.
November 1994, Bioorganic & medicinal chemistry,
O Longo, and S Branca, and M Aloisio
The glycan keratan sulfate in inner ear crystals.
June 1995, Cellular and molecular biology (Noisy-le-Grand, France),
Copied contents to your clipboard!